RALTEGRAVIR POTASSIUM, TABLETS
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
Defense Logistics Agency award SPE2D226F3313 is a delivery order issued on August 28, 2026, under the base administrative contract SPE2DX25D9822. The contract was awarded to DMS Pharmaceutical Group Inc for the procurement of Raltegravir Potassium tablets, identified by NSN 6505016218317 and NDC 00006-0227-61. The total value of this specific order is 1,465.18 dollars for the delivery of one bottle of the medication. The order is managed by the DLA Troop Support Medical Supply Chain FSB and operates under FOB destination terms. This delivery order is part of a larger base contract, SPE2DX-25-D-9822, which was effective as of March 7, 2025, and carries a total award amount of 20,000,000 dollars. The agreement incorporates standard Federal Acquisition Regulation clauses and specifies detailed shipping, inspection, and acceptance protocols for the pharmaceutical delivery.
General Info
Agency
Contract Value
$1,465.18NAICS
Place of Performance
Not specifiedSet-Aside
Awardee
Award Issued Date
Documents
(2)AI Contract Breakdown
Uniform Contract FormatWhat is UCF?
Uniform Contract Format (UCF) uses AI to break down any contract into standardized sections—scope, pricing, deliverables, and evaluation criteria.
Timeline
Organization & Contact Information
Full Description
Similar Contracts
Same NAICS industry code
More opportunities from Department Of Defense → Defense Logistics Agency
Same awarding agency
Ready to Pursue This Opportunity?
Get AI-powered intelligence on this solicitation and the ones like it
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 750+ contractors already using CLEATUS
